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1. Introduction 
Progressive loss of neuronal structure and function occur in several neurodegenerative 
diseases. Cellular responses to brain injury depend on properties of the cells (e.g., hormonal 
nutritional status) and insult (e.g., duration, intensity, and quality), whereas, tissue 
responses depend on interactions between their constituent cells, including chemical and 
electrical transmission as well as paracrine and autocrine signaling. In vertebrate cells, 
autocrine and paracrine communication occur in part via release of chemical signals through 
connexin hemichannels (Sáez et al. 2010), the precursors of gap junction channels that are 
formed by two hemichannels provided by one of each apposed cells (Fig. 1). Each 
hemichannel is composed of six protein subunits termed connexins, which are highly 
conserved proteins encoded by 21 genes in human and 20 in mouse with orthologs in other 
vertebrate species (Cruciani and Mikalsen 2005). Connexins are abundantly expressed in 
cells of the  central nervous system (CNS) (Orellana et al. 2009) (Fig. 2), and they are named 
after their predicted molecular mass expressed in kDa, so that connexin43 (Cx43) has a 
molecular mass of ~43 kDa. 
For a long time the main function attributed to connexin hemichannels was the formation of 
gap junction channels. Nevertheless, in the last decade, the presence of functional connexin 
hemichannels in nonjunctional membranes has been demonstrated by several experimental 
approaches (Sáez et al. 2010). These channels allow cellular release of relevant quantities of 
autocrine/paracrine signaling molecules (e.g., ATP, glutamate, NAD+ and PGE2) to the 
extracellular milieu (Bruzzone et al. 2001; Cherian et al. 2005; Stout et al. 2002), as well as 
uptake of small molecules (e.g., glucose) (Retamal et al. 2007a). Recently, another gene 
family encoding a set of three membrane proteins, named pannexins (Panxs 1-3), has been 
identified (Bruzzone et al. 2003). Up to now, only Panx3 has been shown to form gap 
junctions in osteoblasts (Ishikawa et al. 2011) and further studies will be required to identify 
pannexin gap junctions in other cell types. Connexins and pannexins present similar 
membrane topology, with four α-helical transmembrane domains connected by two 
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extracellular loops, where both N- and C-termini are intracellular. However, there is only 
16% overall identity when their full-length amino acid sequences are compared.  
 
 
Fig. 1. Diagram illustrating basic structures of connexins and undocked hemichannels 
present at the cell surface. The membrane topology of a connexin consists of 4 membrane-
spanning domains (M1-M4), 2 extracellular loops (E1 and E2) and 1 cytoplasmic loop (CL). 
The amino (-NH2) and carboxy (-COOH) terminal tail are intracellular. A hemichannel is 
formed by six connexins that oligomerize laterally leaving a central pore. In cultured cells 
under resting conditions hemichannels remain preferentially closed, but they can be 
activated by diverse physiological and pathological conditions, offering a diffusional 
transmembrane route between the intra and extracellular milieu. [Modified from Orellana et 
al. 2011a] 
A main role in cellular proliferation and tissue remodelling has been attributed to 
hemichannels (Burra and Jiang 2009; Schalper et al. 2008), while in the CNS they have been 
proposed to mediate ischemic tolerance (Lin et al. 2008; Schock et al. 2008) and establish 
adhesive interactions (Cotrina et al. 2008). To date, most studies suggest that under normal 
brain conditions hemichannels release physiological molecules relevant for intercellular 
signalling, including propagation of intercellular Ca2+ waves (Orellana et al. 2011a). However, 
an increasing body of evidence has situated the hemichannels as potential regulators of the 
beginning and maintenance of homeostatic imbalances present in diverse brain diseases 
(Orellana et al. 2009). Pioneering findings by Contreras and co-workers (Contreras et al. 
2002) showed that astroglial death induced by ischemia-like conditions is accelerated by the 
opening of Cx43 hemichannels. In this sense, a constant increase of [Ca2+]i mediated by 
augmented Ca2+ entry through hemichannels, which are permeable to Ca2+ (Schalper et al. 
2010), and deficient or insufficient Ca2+ handling by injured cells could lead to cell death. 
Here, we review and discuss the current evidence about the role of hemichannels in three 
major neurodegenerative diseases, namely, bacterial meningitis, stroke and Alzheimer's 
disease. 
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Fig. 2. Cellular distribution of pannexin and connexin hemichannels and connexin gap 
junctions in brain cells. This figure includes only those cases in which the available 
information has been obtained in vivo and/or in vitro with more than one experimental 
approach.  Homocellular connexin gap junction channels and connexin and pannexin 
hemichannels are indicated within the encircled regions.  Neuron (N), astrocyte (A), 
microglia (M) and oligodendrocyte (O). [Modified from Orellana et al. 2009]  
2. What is known about hemichannels in neurological disorders? 
2.1 Bacterial meningitis 
Despite the advances in the understanding of infectious diseases, including bacterial 
meningitis, pathogen-host interactions and the widespread use of chemotherapeutic agents, 
infections are still an important cause of mortality, morbidity and social burden worldwide. 
Bacterial meningitis promotes inflammation of the pia, arachnoid, and subarachnoid space. 
Inflammation may also affect the brain parenchyma leading to encephalitis. Bacteria present 
in the bloodstream induce an innate immune response which produces systemic release of 
cytokines, mainly TNF-α (Dietzman et al. 1974; Ring et al. 1998). Then, bacteria colonize and 
cross the inflamed blood-brain barrier (BBB) and components of their wall, such as 
lipopolysaccharide (LPS) (Bannerman et al. 1998), peptidoglycan (PGN) (Bannerman et al. 
1998), or streptococcal hemolysin/cytolysin (Doran et al. 2003), induce BBB activation and 
permeabilization (Freyer et al. 1999) (Fig. 3). BBB activation is characterized by numerous  
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Fig. 3. Connexin based channels in brain cells during bacterial meningitis. During bacterial 
infection blood levels of cytokine (e.g., TNF-α and IL-1ǃ) are elevated. Both, TNF-α and  
IL-1ǃ enhance the hemichannel activity (1) of brain endothelial cells. Furthermore, these 
cytokines induce BBB discontinuity favoring bacterial extravasation (2). Once in the 
interstitium, bacteria and their extracellular wall components such as LPS and PGN are 
recognized by microglia (3), which are activated and release cytokines that further activate 
them (reciprocal arrows). ATP released via hemichannels from microglia (4) promotes 
microglial migration from less affected regions. Activated microglia can also release 
glutamate through hemichannels and oxygen and nitrogen derived free radicals that are 
neurotoxic (5). The enhanced hemichannel activity of activated astrocytes induces neuronal 
damage through the release of neurotoxic and/or inflammatory compounds such glutamate 
and PGE2 (6). These compounds may also increase the activity of neuronal 
connexin/pannexin hemichannels (7) causing electrochemical imbalance and Ca2+ overload 
in neurons. In contrast to increased opening of hemichannels, astroglial gap junction 
communication is reduced (8), impairing glutamate and K+ spatial buffering that enhances 
neuronal susceptibility to insults. Bacterial meningitis can also induce demyelination (9), 
possibly via microglial cytokine release. Severe inflammation induces recruitment of 
leukocytes (10) to the infected loci. Gap junction communication between leukocytes and 
endothelial cells (11) may contribute to strength heterocellular adhesion and allow transfer 
of signals that regulate leukocyte diapedesis across the endothelium (12). Activated 
microglia may perform antigen cross-presentation interaction with infiltrating leukocytes in 
which gap junctions between them may play an important role (13).  Direct microglial 
interaction with LPS or PGN induces gap junction communication between microglia, 
which can coordinate microglial function (14). [Modified from Orellana et al. 2009] 
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changes including cytokine production, overexpression of cell adhesion molecules and 
NO synthesis (Freyer et al. 1999). Recently, hemichannels have been implicated in the 
pathogenesis of bacterial meningitis.  Using a model of bacterial brain abscess, Karpuk 
and co-workers (Karpuk et al. 2011) showed that a transient hemichannel activity is 
induced in astrocytes within close proximity to the abscess border, which dissipates with 
increasing distance from the inflammatory site. Moreover, this transient hemichannel 
opening was blocked with the Cx43 mimetic peptide Gap26, carbenoxolone, the Panx1 
mimetic peptide 10panx1, and probenecid (Karpuk et al. 2011), indicating the involvement 
of both Cx43 and Panx1 hemichannels in this response. In addition, astroglial gap junction 
coupling was significantly reduced in areas immediately surrounding the abscess 
margins, while regions far from abscess presented normal coupling (Karpuk et al. 2011). 
These data are consistent with previous studies showing opposite regulation of gap 
junction channels versus hemichannels in astrocytes subjected to pro-inflammatory 
conditions (Froger et al. 2010; Froger et al. 2009; Orellana et al. 2011b; Orellana et al. 2010; 
Retamal et al. 2007a).  
Pioneering findings by Retamal and co-workers (Retamal et al. 2007a) showed that TNF-α 
and IL-1ǃ released from LPS-treated microglia induce an increase and decrease in astroglial 
hemichannel and gap junction channel activity, respectively (Retamal et al. 2007a).  
The consequence of this opposite regulation on the homeostasis of the infected and 
uninfected brain parenchyma and how they may influence CNS function remain to be 
elucidated. A possible consequence of increased astroglial hemichannel opening could be 
an enhanced glucose uptake, which might explain the observed changes in the metabolic 
status of astrocytes under inflammatory conditions (Rtamal et al. 2007a). Moreover, 
hemichannel-mediated astroglial release of neurotoxic and/or inflammatory compounds 
such as glutamate and ATP could promote paracrine neuronal damage (Iglesias et al. 
2009; Jiang et al. 2011; Kang et al. 2008; Orellana et al. 2011b; Orellana et al. 2011c; Ye et al. 
2003). 
Since the BBB critically regulates the passage of molecules into the CNS, the possibility of 
defective hemichannels in cells of the BBB during bacterial meningitis may be relevant. In 
this regard, TNF-α blocks the ATP release induced by photoliberation of InsP3 or zero 
[Ca2+]o, but increases the basal ATP release and hemichannel-mediated dye uptake in brain 
cortical endothelium derived cell lines, RBE4 and GP8 (Vandamme et al. 2004). Since the 
increase in basal ATP release induced by TNF-α is not affected by the mimetic peptide 
Gap26, a prominent blocker of InsP3- and zero Ca2+-triggered connexin-dependent ATP 
release (Braet et al. 2003), it was concluded that the InsP3- and zero Ca2+-induced ATP 
release would involve a mechanism distinct from the one involved in the TNF-α induced 
elevation of basal ATP release (Vandamme et al. 2004). However, the authors did not rule 
out the involvement of other type of hemichannels (connexin/pannexins), including 
hemichannels formed by Cx40, which is highly expressed in brain endothelial cells 
(Nagasawa et al. 2006). Thus, the rise in basal activity induced by TNF-α could be related to 
Cx40 and/or pannexin hemichannels. At least in peripheral endothelial cells, the ATP 
release induced by brief exposure to PGN depends exclusively on Cx43 hemichannels 
(Robertson et al. 2010). 
Enhanced endothelial hemichannel activity could elevate the ATP release, which would 
recruit microglia to the injury site (Davalos et al. 2005). In agreement with a role of 
hemichannels in ATP release during inflammatory conditions triggered by bacterial 
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infections, Shigella infection of epithelial cells promote ATP release through Cx26 
hemichannels, resulting in the activation of purinergic receptors on neighboring cells and 
bacterial dissemination (Tran Van Nhieu et al. 2003). In the same way, normal calcium 
signaling between astrocytes could be affected under pro-inflammatory conditions, eliciting 
one of the two calcium waves reported (Orellana et al. 2011a) (Fig. 4). In one of them, Ca2+ 
waves propagate by diffusion of cytoplasmic inositol (1,4,5)-trisphosphate (IP3) through gap 
junctions between astrocytes, after phospholipase C (PLC) activation (Fig. 4). Evidence for 
this mechanism includes: (i) the waves are dependent on gap junctional communication; (ii) 
the waves are not blocked by extracellular apyrase, which is an ATPase; (iii) are not blocked 
by purine-receptor antagonists such as suramin; and (iv) do not jump a gap between cells 
(Orellana et al. 2011a). Other possible mechanism for astroglial Ca2+ waves is through the 
ATP released by Cx43 and/or Panx1 hemichannels after ATP-mediated P2 receptor 
activation (Fig. 4). Evidence for this mechanism include: (i) the waves require Cx43 and/or 
Panx1 expression (ii) hemichannel blockers prevent the waves; (iii) ATP is released by the  
 
 
Fig. 4. Two models for conduction of Ca2+ waves in astrocytes. (Top panel) Upstream 
receptor stimulation leads to activation of phospholipase C (PLC) and formation of 
cytoplasmic inositol (1,4,5)-trisphosphate (IP3), which promote the release of Ca2+ stored in 
the endoplasmic reticulum. Both IP3 and Ca2+ diffuse to neighboring cells through gap 
junction channels generating waves of rises in intracellular Ca2+ concentration [Ca2+]i. 
(Bottom panel) ATP released from vesicles and/or ion channels diffuses through the 
extracellular space and activates membrane purinergic (P2) receptors. Stimulation of 
metabotropic P2Y receptors leads to activation of phospholipase C (PLC) and formation of 
IP3. Whereas, activation of ionotropic P2X receptors leads to Ca2+ influx. The increase in free 
[Ca2+]i induced by IP3 and P2X receptor opening could promote ATP release through Cx43 
and Px1 hemichannels, extending the Ca2+ wave to neighboring cells. [Modified from 
Orellana et al. 2011a] 
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initiator cell, and the Ca2+ waves extend as far as the ATP diffuses; (iv) the waves are 
blocked by extracellular apyrase; (v) are blocked by suramin (P2 receptor blocker); and (vi) 
jump cell-free gaps and are deflected by flow of medium (Orellana et al. 2011a). Probably, 
in vivo these two mechanisms coexist and are subjected to regulation by neuro- and glio-
transmitters, playing a key role in the functional synchronization of neurovascular 
coupling.   
As mentioned before, in the brain parenchyma, bacteria may undergo lysis and thus, they 
release pro-inflammatory and toxic factors such as PGN and LPS (Stuertz et al. 1998; Stuertz 
et al. 1999), while microglia interact directly with intact bacteria (Kim 2003). Bacterial 
derived pro-inflammatory factors such as LPS induce neurodegeneration (Qin et al. 2007). 
PGN and LPS stimulate microglial Toll-like receptors (TLRs), induce translocation of nuclear 
factor (NF) κB (Schwandner et al. 1999), and activation of MAPK signaling and transcription 
of genes encoding inflammatory cytokines (Laflamme and Rivest 2001; Nau and Bruck 
2002). Moreover, PGN increases microglial Cx43 mRNA and protein expression, which 
correlates with development of gap junction communication in vitro (Garg et al. 2005). 
Similarly, treatment with LPS plus IFN-Ǆ increases Cx43 expression in rat microglia and 
induces gap junction communication (Eugenín et al. 2001). In addition, brain stab wounds 
induce recruitment of Cx43 immunoreactive microglia to the injured foci, suggesting that 
Cx43 is important for coordinating microglial responses (Eugenín et al. 2001). However, up 
to now, the functional state of hemichannels in microglia has been not examined in model of 
bacterial brain infection. 
Bacterial meningitis also causes axonal damage and demyelination (Nau et al. 2004). These 
effects may be related to microglial cytokine release, which could promote opening of 
oligodendrocyte hemichannels, possibly composed of Panx1, Cx32 or Cx29 [Cx29 does not 
form gap junctions and faces the periaxonal space (Li et al. 2002)] and, thus, promoting ion 
gradient imbalance and Ca2+ overload. 
Adhesion between leukocytes and endothelial cells could result in part from leuko-
endothelial gap junction formation (Veliz et al. 2008). In fact, treatment with diverse gap 
junction channel blockers reduces leukocyte adhesion to venular endothelium in vivo (Veliz 
et al. 2008) as well as transmigration across a BBB model (Eugenín et al. 2003). Gap junctions 
between lymphoma and endothelial cells have also been demonstrated, and α-GA 
attenuates the transmigration of lymphoma cells across an endothelial barrier (Haddad et al. 
2008). However, it is important to keep in mind that most gap junction blockers will also 
block hemichannels and that connexin knockout animals will also have impaired 
transmembrane diffusional transport mediated by hemichannels. Indeed, the autocrine 
release of ATP through Cx37 hemichannels in monocyte/macrophages limits their adhesion 
to the endothelial wall and recruitment to the subendothelial compartment (Wong et al. 
2006). Recent findings also suggest that connexin and pannexin hemichannels participate in 
acute and chronic inflammatory responses mediated by macrophagic cells. In fact, LPS or 
TNF-α promote microglial release of neurotoxic glutamate concentrations via Cx32 
hemichannels (Takeuchi et al. 2006). Panx1 hemichannel opening occur in primary 
macrophages, macrophage cell lines and microglia exposed to pro-inflammatory conditions 
(Orellana et al. 2011c; Pelegrin and Surprenant 2006; Pelegrin and Surprenant 2007). In 
addition, caspase-1/inflammasome-mediated release of members of the IL-1 family 
including IL-1ǃ from mouse peritoneal macrophages requires hemichannel activation 
through P2X7 purinergic receptors (Pelegrin and Surprenant 2006).  
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2.2 Stroke 
Stroke is a major cause of death in industrialized countries and results from a transient or 
permanent reduction in cerebral blood flow produced, in most cases, by cerebral artery 
occlusion by an embolus or local thrombosis, i.e., focal ischemia (Dirnagl et al. 1999). Severe 
and/or prolonged reduction in cerebral blood flow leads to deprivation of oxygen and 
glucose as well as build-up of potentially toxic substances. During stroke, decreased cellular 
oxygen levels, loss of oxidative phosphorylation and reduced ATP synthesis are the initial 
steps leading to cell death (Dirnagl et al. 1999). The ATP depletion may induce a rapid 
decrease in ATPase activity, leading to imbalanced electrochemical gradients across the 
plasma membrane. Notably, increased pannexin and/or connexin hemichannel activity 
occur in cortical astrocytes (Contreras et al. 2002; Orellana et al. 2011b; Orellana et al. 2010; 
Retamal et al. 2006), olygodendrocytes (Domercq et al. 2010) and hippocampal neurons (Lin 
et al. 2008; Schock et al. 2008; Thompson et al. 2006) subjected to ischemic like conditions. 
The enhanced hemichannel activity induced by ischemic like conditions accelerates cell 
death, at least in cultured rat astrocytes (Contreras et al. 2002; Orellana et al. 2010) (Fig. 5). 
Possibly, sustained hemichannel opening contribute to increased [Ca2+]i, which in turn may 
favour even more the connexin hemichannel activity (De Vuyst et al. 2007; Schalper et al. 
2008), inducing Ca2+ and Na+ intracellular overload (Fig. 5). The ionic (or electrolyte) 
imbalance leads to an osmotic imbalance that results in cell swelling and plasma membrane 
phospholipase A2, with the subsequent generation of arachidonic acid and activation of  
 
 
Fig. 5. Three mechanisms of death amplification. (A) Initially, a brain injury produced by 
ischemia, infection or necrosis affecting astrocytes (green), neurons (orange) or resting 
microglia (blue), could  start  a wave of death propagated (yellow arrows)  and amplified 
through diffusible toxins and molecules (e.g., Ca2+, NO, superoxide ion, peroxinitrite, 
glutamate, and NAD+) present in high concentration in injured cells (depicted in the figure 
as dark colored cells). These molecules could be transferred through connexin gap junctions 
and connexin and pannexin hemichannels from injured cells (less and more affected cells in 
gray and black, respectively) to healthier cells. (B) Later, a second wave of death (yellow 
arrows) may be mediated by microglial cells overactivated by ATP and cytokines released 
by injured cells. (C) Still later inflammation-induced edema that reduces tissue perfusion 
could worsen the inflammatory response, recruiting leucocytes and increasing the extent of 
the lesion. [Modified from Orellana et al. 2009] 
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breakdown as observed in astrocytes exposed to ischemic conditions (Kimelberg 2005)  
(Fig. 5). Calcium overload induced in part by hemichannel opening may also activate 
cyclooxygenase/lipoxygenase pathways leading to increased free radicals, lipid 
peroxidation and further plasma membrane damage. It is noteworthy that arachidonic acid 
and decrease in the intracellular redox potential also activates Cx43 hemichannels, which 
may exacerbate cell damage (De Vuyst et al. 2009; Retamal et al. 2007b).  
The first in vivo evidence for the involvement of connexin-based channels in the spread of 
death signals came from experiments in which octanol, a non-selective gap junction and 
hemichannel blocker, reduced the infarct size after focal cerebral ischemia (Rawanduzy et al. 
1997). However, these observations disagree with the findings obtained in heterozygous 
Cx43 knockout mice or mouse astrocytes lacking Cx43 expression, in which focal ischemia 
causes larger lesions (Nakase et al. 2003; Nakase et al. 2004; Siushansian et al. 2001). In a rat 
model of transient global ischemia, pretreatment with compounds that block both 
hemichannels and gap junction channels (i.e. CBX, α-GA and endothelin) reduces the 
number of apoptotic neurons as compared to the contralateral hippocampus treated with 
saline (Perez Velazquez et al. 2006). In addition, hemichannels present in surrounding cells 
or in the stromal component of diverse organs may also participate in the ischemic 
responses. For example, the CA1 region of Cx32- deficient mice show increased sensitivity 
to global ischemia (Oguro et al. 2001). Since Cx32 forms hemichannels in activated microglia 
(Takeuchi et al. 2006), it is possible that Cx32 knockout animals may show attenuated 
microglial release of regulatory paracrine signals. When acute diseases like stroke have the 
presence of other pro-inflammatory components (e.g. high glucose produced by diabetes 
mellitus), brain damage and cognitive functions in patients is worse (Pasquier et al. 2006). 
Indeed, it has long been known that hyperglycemia worsens the outcome of acute brain 
ischemia by increasing the extent of tissue injury in animals and humans (Kagansky et al. 
2001). Recently, we showed in astrocytes that high levels of extracellular glucose increase 
hemichannel activity and decrease gap junction permeability induced by hypoxia (Orellana 
et al. 2010). These changes are transient after 3 hours of hypoxia in high glucose. However, 
they are more prominent after 6 hours of hypoxia and last for over 3 hours followed by 
death of numerous astrocytes (Orellana et al. 2010). Because high glucose worsens the effect 
on ischemia-induced cell damage in endothelial cells, neurons, and microglia (Kagansky et 
al. 2001; Lin et al. 1998a; Tsuruta et al. ; Wang et al. 2001), it would be of interest to study if 
elevated hemichannel activity plays a relevant role as in astrocytes. Importantly, we also 
demonstrated that microglia treated with amyloid ǃ peptide (Aǃ) potentiate the increase in 
astroglial hemichannel activity and reduction in gap junctional communication induced by 
hypoxia in high glucose, suggesting that these changes are a common denominator of 
inflamed or activated astrocytes (Orellana et al. 2011b) (Fig. 6).  
In addition, the extracellular media of activated astrocytes was neurotoxic due to its 
glutamate and ATP content that activate neuronal Panx1 hemichannels via NMDA/P2X 
receptors leading to neuronal death (Orellana et al. 2011b). Therefore, in a more integrated 
system (e.g., brain or brain slices) neurons could be efficiently protected from ischemia and 
neurotoxicity by blocking NMDA and P2X receptors as already proposed (Dirnagl et al. 
1999), but also by targeting either glial or neuronal hemichannels composed by Cx43 and 
Panx1, respectively.  
Hemichannels may also be involved in tissue response to stroke through their participation 
in a phenomenon known as ischemic preconditioning, in which a sublethal ischemic insult 
induces resistance to a subsequent more severe insult (Gidday 2006). It was recently shown  
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Fig. 6. Involvement of extracellular signals released by inflamed glial cells in neuronal death. 
Activated microglia (by for example Aǃ) release pro-inflammatory cytokines (e.g., TNF-α 
/IL-1ǃ), which increase astroglial hemichannel activity when another pro-inflammatory 
agent is involved (e.g., hypoxia). Then, astrocytes release glutamate and ATP via Cx43 
hemichannels, which can activate more microglia and could promote activation of neuronal 
NMDA and P2X receptors and further opening of Panx1 hemichannels in neurons. ATP 
released as a result of Panx1 hemichannel opening could contribute to the progression of 
neuronal death by a vicious cycle since it will activate more P2X receptors leading to more 
Ca2+ entry and activation of intracellular neurotoxic cascades. Moreover, dead neurons can 
activate more microglia and thus, can either restart or potentiate the toxic circuit. [Modified 
from Orellana et al. 2011b] 
that preconditioning reduces degradation of Cx43 in astrocytes, leading to a marked 
increase in the amount of surface Cx43 hemichannels (Lin et al. 2008). In agreement with the 
possible involvement of hemichannels in preconditioning responses, Cx43 null mice are 
insensitive to hypoxic preconditioning whereas wild-type littermates mice exhibit a 
prominent reduction in infarct volume after induction of preconditioning through occlusion 
of the middle cerebral artery (Lin et al. 2008). The mechanism of neuroprotection in this 
model involves the release of ATP through Cx43 hemichannels to the extracellular milieu, 
where it becomes hydrolyzed to adenosine, a potent neuroprotective molecule. The 
involvement of Cx36 hemichannels in the preconditioning response of cultured cerebellar 
granule neurons has been also recently demonstrated (Schock et al. 2008). The possible 
involvement of pannexin based hemichannels in brain preconditioning responses remains 
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unknown. Final demonstration of the relative importance of enhanced hemichannel activity 
on cell viability during ischemia in vivo will require new approaches including better 
controlled experimental models and molecules that selectively block connexin- or pannexin-
based hemichannels. 
2.3 Alzheimer's Disease 
Alzheimer’s Disease (AD) is an age-related neurodegenerative disease that results in 
memory loss, behaviour and personality changes, among other symptoms. This disorder is 
characterized by the accumulation of the Aǃ into amyloid plaques in the extracellular brain 
parenchyma, formation of tangles inside neurons as a result of abnormal phosphorylation of 
the microtubule associated protein tau, dendritic atrophy, and changes in neurotransmission 
in specific brain regions (Parihar and Hemnani 2004). Aǃ is generated by proteolytic 
cleavage of the amyloid precursor protein (APP), which plays a role in neuronal adhesion, 
synaptogenesis, and axonal growth (Parihar and Hemnani 2004). High concentrations of Aǃ 
are toxic to several neuronal types (Loo et al. 1993; Parihar and Hemnani 2004; Pike et al. 
1995). The mechanisms underlying Aǃ-neurotoxicity are complex but involve activation of 
NMDA receptors, sustained elevations of [Ca2+]i, and oxidative stress (Ekinci et al. 2000; 
Forloni et al. 1993), which are effects common to those induced by ischemia-reperfusion but 
on a different time scale.  
In addition to the above, the cerebral cortex of individuals with AD present activated 
microglia and astroglia closely associated with amyloid plaques (Kalaria 1999; Wisniewski 
and Wegiel 1991). Notably, increased Cx43 immunoreactivity is detected in about 80% of Aǃ 
plaques in postmortem human samples from AD patients (Nagy et al. 1996). Accordingly, a 
recent study performed in a murine model of AD showed that the immunoreactivity for Cxs 
30 and 43 is increased at the proximity of most Aǃ plaques (Mei et al. 2010). Imbalance in 
brain homeostasis may explain the increase expression of Cxs 30 and 43 close to amyloid 
plaques as compensatory mechanism to ensure normal brain function (Mei et al. 2010)(Nagy 
et al. 1996). Alternatively, increased astroglial gap junctions may serve as a pathway for the 
propagation of neuronal damage, transferring death signals generated in the 
microenvironment of amyloid plaques to distant neurons, as death signals can propagate 
from C6 glioma cells injured with calcium ionophore (Lin et al. 1998b). In agreement with 
this interpretation, inhibition of gap junctions with octanol abolishes the ability of Aǃ to 
enhance the velocity and extent of propagation of astroglial calcium waves (Haughey and 
Mattson 2003). However, octanol also blocks P2X7 receptors expressed by spinal astrocytes 
that also show calcium waves (Suadicani et al. 2006). In support of P2 receptor mediation of 
the Aǃ-induced increase of calcium wave velocity in cortical astrocytes is the fact that 
suramin, a P2Y and P2X receptors blocker, reduces this response (Haughey and Mattson 
2003). 
Recently, it was shown that the treatment with the neurotoxic fragment of Aǃ, 25-35 (Aǃ25-35) 
increases hemichannel opening in microglia, astrocytes and neurons monitored by single-
channel recordings and by time-lapse ethidium uptake (Orellana et al. 2011c). The 
hemichannel forming proteins responsible of this activity were Cx43 and Panx1 in the case 
of microglia, Cx43 in the case of astrocytes and Panx1 and possibly Cx36 in neurons 
(Orellana et al. 2011c). Moreover, Aǃ25-35 increased the surface level of Cx43 in microglia and 
astrocytes and for the first time it was detected an increase in surface Panx1 in Aǃ25-35 -
treated microglia (Orellana et al. 2011c). Panx1 was also detected in astrocytes, but not at 
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their surface, either in the absence or presence of Aǃ25-35, which is in disagreement with a 
recent study in which astroglial Panx1 hemichannels were activated by extracellular ATP 
(Iglesias et al. 2009). Importantly, conditioned media harvested either from Aǃ25-35-treated 
microglia or astrocytes, increased neuronal ethidium uptake and mortality, an effect 
prevented by inhibitors of P2X/NMDA receptors and Panx1 hemichannels, indicating that 
ATP and glutamate contribute to these changes (Orellana et al. 2011c). The contribution of 
these two molecules in neurotoxicity is well known (Lipton and Rosenberg 1994) and the 
involvement of hemichannels in glutamate and ATP release has also been documented  
 
 
Fig. 7. Model of Aǃ-induced cascade resulting in glial and neuronal hemichannel activation 
that leads to neuronal death. Microglia exposed to the amyloid ǃ (Aǃ) peptide become first 
activated (1), enhancing the opening of Cx43 and Panx1 hemichannels. Under these 
conditions, they release pro-inflammatory cytokines (2) that contribute to the Aǃ-induced 
Cx43 hemichannel opening in astrocytes (3). Activated microglia might release glutamate 
and ATP through hemichannels (4), while astrocytes could release the same molecules 
through Cx43 hemichannels (5). This gliotransmission activates neuronal purinergic and 
NMDA receptors, resulting in an elevation of the intracellular free Ca2+ concentration that 
might trigger massive Cx36 and Panx1 hemichannel opening and further neuronal death (6). 
[Modified from Orellana et al. 2011c] 
(Iglesias et al. 2009; Jiang et al.; Kang et al. 2008; Orellana et al. 2011b; Orellana et al. 2011c; 
Takeuchi et al. 2006; Ye et al. 2003). Moreover, these two molecules were shown to induce 
neuronal death via activation of Panx1 hemichannels in neurons (Orellana et al. 2011b). 
Their effect on neuronal death may proceed according to at least two mechanisms:  
1) through the stimulation of NMDA and/or P2X receptors or 2) through Cx36 and Panx1 
hemichannels themselves that could evoke large Ca2+ influxes resulting in neuronal death 
(Orellana et al. 2009) (Fig. 7).  
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Moreover, these two mechanisms could also be linked since transient activation of NMDA 
receptors induced a nonselective cationic current that develops slowly and mediates Ca2+ 
influx directly linked to neuronal death. Interestingly, this secondary current was reported 
recently to be mediated by neuronal Panx1 hemichannels (Thompson et al. 2008). Moreover, 
activation of Panx1 hemichannels might be triggered by protein–protein interaction with 
activated P2 receptors (Iglesias et al. 2008). Alternatively, Panx1 hemichannels could be 
activated by the rise in [Ca2+]i caused by opening of NMDA and P2X receptors (Locovei et 
al. 2006). In this mechanism, neuronal ATP released as a result of Panx1 hemichannel 
opening is also likely to contribute in the progression of neuronal death by a vicious cycle 
since it will activate more ionotropic P2 receptors enhancing the Ca2+ entry and activation of 
intracellular neurotoxic cascades (Fig. 7). Studies in AD models will help to confirm or reject 
the above interpretations.  
3. Conclusions 
In the last decade, connexin hemichannels have been implicated in paracrine and autocrine 
cellular communication in several normal and pathologic conditions (Sáez et al. 2010). 
Currently, most of the available data regarding hemichannel involvement in brain 
pathologic events are from cultured cells and animal models of diseases. However, the 
current knowledge of human brain disease processes and the documented presence of 
hemichannels forming proteins in most studied human CNS tissues allows to speculate 
about the involvement of hemichannels in neurodegenerative processes. The role of glial 
cells in mediating nervous tissue inflammation has been recognized previously as leading to 
neuronal death; these cells can be bad neighbours for neurons (Block et al. 2007). 
Dysfunction of astroglial and microglial hemichannels, as well as gap junction channels, are 
likely mechanisms commonly elicited in all brain diseases associated with inflammatory 
responses. Therefore, normalization of connexin- and pannexin-based channel dysfunctions 
should confer tissue protection, improve quality of life, and extend survival of patients 
suffering acute or chronic brain inflammatory responses. Thus, it is proposed that chronic or 
acute processes of neurodegeneration might be prevented by blocking glial and neuronal 
hemichannels. Prevention might also be accomplished by reducing the effects of soluble 
factors (i.e., glutamate, ATP, prostaglandins, and cytokines) accumulated in the 
microenvironment of the inflamed CNS. 
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degeneration. A section discusses how neighboring glial cells modulate or promote neurodegeneration. In the
next section an evaluation is given of how hormonal and metabolic control modulate disease progression,
which is followed by a section exploring some preventive methods using natural products and new
pharmacological targets. We also explore how medical devices facilitate patient monitoring. This book is
suitable for different readers: college students can use it as a textbook; researchers in academic institutions
and pharmaceutical companies can take it as updated research information; health care professionals can
take it as a reference book, even patients' families, relatives and friends can take it as a good basis to
understand neurodegenerative diseases.
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